Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) 2.47-5.634.24-9.38-22.70

What is the latest Core EBITDA Growth ratio of AARTI DRUGS ?

The latest Core EBITDA Growth ratio of AARTI DRUGS is 2.47 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar20262.47
Mar2025-5.63
Mar20244.24
Mar2023-9.38
Mar2022-22.70

How is Core EBITDA Growth of AARTI DRUGS Trending?

Years Core EBITDA Growth % Change
Mar2026 2.47
Positive
Mar2025 -5.63
Negative
Mar2024 4.24
Positive
Mar2023 -9.38
Negative
Mar2022 -22.7 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Growth ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,747.0 Cr -3.3% -2.4% -17.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,466.0 Cr -2.3% -5.9% 6.2% Stock Analytics
DIVIS LABORATORIES ₹246,222.0 Cr -1.7% -1.1% 60.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹176,300.0 Cr -2.1% -5.1% 32.2% Stock Analytics
CIPLA ₹107,447.0 Cr -2.2% -4% -13.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,471.0 Cr 1.8% 7.6% -4.3% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-3.3%

-2.4%

-17.2%

SENSEX

-0.1%

-2.3%

-10.7%


You may also like the below Video Courses